Keywords: Valves, Quantitative Imaging, Mitral Valve Regurgitation, Hemodynamic Force, Novel Biomarker
Motivation: This study aims to address shortcomings in assessing mitral regurgitation (MR) by introducing left ventricular hemodynamic force (HDF) as a novel biomarker.
Goal(s): The primary objective of this study is to assess HDF's reliability through 4D flow MRI in distinguishing MR patients from healthy controls and stratifying severity, offering a more precise diagnostic tool.
Approach: This retrospective analysis used 4D flow MRI data to compute HDF in three directions, evaluating its correlation with MR.
Results: MR patients exhibit significantly altered HDF compared to controls. The HDF: peak systolic base-apex, E-wave inferior-anterior, E-wave base-apex, and peak diastolic septal-lateral suggest their potential as mitral biomarkers.
Impact: The introduction of hemodynamic force as a novel biomarker opens new research avenues, potentially reshaping cardiac non-invasive diagnostic techniques. This study may transform the assessment of mitral regurgitation, offering benefits to clinicians for early intervention and proper patient management.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords